DaCCoTA

Welcome to the Dakota Cancer Collaborative on Translational Activity.

What is the DaCCoTA?

daccota The goal of the DaCCoTA is to bring together researchers and clinicians with diverse experience from across the region to develop unique and innovative means of combating cancer in North and South Dakota.

We believe advances in cancer treatment will come from broad approaches by collective groups of clinical and basic researchers who are focused on conducting clinical/translational research.

The DaCCoTA is supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number U54GM128729.

Funding Opportunities Offered Through the DaCCoTA

Request for Applications for DaCCoTA Community Engagement Pilot Awards

The Community Engagement Pilot Grant Awards are intended for those projects addressing priority areas as determined by key stakeholder groups including the American Cancer Society, Community Health Association of the Dakotas, ND Department of Health, and the Great Plains Tribal Chairmen’s Health Board. Proposals should address cancer disparities in either:

Colorectal cancer screening, stage and diagnosis, treatment, and mortality
Tobacco-related cancers (Lung, CRC, etc.) or
Breast cancer screening, stage at diagnosis, and mortality

Deadline for Assistance Finding a Collaborator:

October 16, 2020

Letter of Intent Due Date

October 30, 2020

Application Due Date

February 1, 2021

Anticipated Award Period

September 2021 - August 2022

Request for Applications for DaCCoTA Feasibility Pilot Awards

The Feasibility Pilot Awards are designed to allow a clinician/non-clinician team to form around a novel cancer-related hypothesis. Applications can consider the multilevel manifestations of cancer (e.g. neurological, psychiatric), demographic risks and social impact. Applications should focus on T2-T4 translational research, although T1 studies will be considered if there is a clear plan to progress to T2-T4. The primary goal is to allow a team to form and connect with the CTR Biostatistics, Epidemiology, and Research Design Core; Clinical Research Resources and Facilities Core; Community Engagement and Outreach Core; and Pilot Projects Program to generate competitive proposals for the Ready-to-Go Pilot Award mechanism.

Deadline for Assistance Finding a Collaborator:

October 16, 2020

Letter of Intent Due Date

October 30, 2020

Application Due Date

February 1, 2021

Anticipated Award Period

September 2021 - August 2022

Request for Applications for DaCCoTA Ready-to-Go Pilot Awards

The Ready-to-Go Pilot Awards are intended for those projects with existing significant preliminary data in support of a novel clinical/translational cancer-related hypothesis. These projects should ideally be ready for extramural submission within a year and/or be able to demonstrably improve health outcomes. Applications can consider the multilevel manifestations of cancer (e.g. neurological, psychiatric), demographic risks and social impact. Applications will focus on T2-T4 translational research, although T1 studies will be considered if there is a clear plan to progress to T2-T4. Successful completion of these proposals should lead to a collaborative extramural grant submission and peer-reviewed manuscript submission.

Deadline for Assistance Finding a Collaborator:

October 16, 2020

Letter of Intent Due Date

October 30, 2020

Application Due Date

February 1, 2021

Anticipated Award Period

September 2021 - August 2022

Visit the Pilot Projects Program for more information.

The DaCCoTA Pathfinder

By enrolling in the DaCCoTA Pathfinder, you will be able to search and view the research profiles of other scientists and clinicians in the DaCCoTA network to find collaborators. You will belong to a network of colleagues and collaborators with shared research interests and gain access to educational and training opportunities.

Enroll in the Pathfinder web portal to find collaborators

You will also be able to access various clinical and translational research resources including the Biostatistics, Epidemiology, and Research Design Core; the Community Engagement and Outreach Core; the Professional Development Core; the Pilot Projects Program; and the Clinical Research Resources and Facilities Core.

Explore the resources available through the DaCCoTA

Our Partners

DaCCoTA investigators may also wish to explore partnerships with the Turtle Mountain Genetics Laboratory

What is Clinical Translational Research?

Clinical/translational research (CTR) focuses on translating findings from basic research into clinical applications with the overall goal of improving the health of the community.

componentsandgoals